logo
logo
AI Products 

Track etched Membrane Market Worth USD 813.1 million by 2023 : R&D Spending in the Pharmaceutical

avatar
Research Net
Track etched Membrane Market Worth USD 813.1 million by 2023 : R&D Spending in the Pharmaceutical

This report aims to provide detailed insights into the global track etched membrane market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Revenue Growth Analysis:

[140 Pages Report] The track etched membrane market was valued at 428.4 million in 2017 and is projected to grow at a CAGR of 11.3%.

Download PDF Brochure: 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42556211

Key Factors Driving Market Growth:

The growth of the pharmaceutical R&D expenditure is expected to be one of the major factors driving the growth of this market during the forecast period. Moreover, the collaborative application of nanotechnology and track etching is expected to increase the adoption of Track etched Membranes in various applications, such as healthcare, fuel cells, telecommunications, and transportation

By product, the membrane filters segment is estimated to account for the largest share of this market

Based on product, this market is segmented into membrane filters, cartridge & capsule filters, and other Track etched Membrane products. The membrane filters segment is estimated to account for the largest share of the global Track etched Membrane Market in 2018. The large share of this segment can be attributed to the increasing applicability of membrane filters in sterilizing, final filtration, sample preparation, filtration of aqueous and organic solutions, fluid monitoring, and venting and gas filtration.

By application, the cell biology segment is expected to hold the largest share of the Track etched Membrane Market

Based on application, the Track etched Membrane Market is segmented into cell biology, microbiology, analytical testing, and other applications. Of all these application segments, the cell biology segment is expected to lead Track etched Membrane Market in 2018. The large share of this segment can be attributed to its increasing applications in pharmaceutical and biopharmaceutical industries for research activities.

The pharmaceutical & biopharmaceutical companies' segment is projected to dominate Track etched Membrane Market

By end user, the Track etched Membrane Market is segmented into pharmaceutical & biopharmaceutical companies, academic & research institutes, food & beverage companies, hospital & diagnostic laboratories. Pharmaceutical and biopharmaceutical companies are the largest end-users of Track etched Membranes majorly due to the growing research towards the development of biological molecules, increasing manufacturing of generic drugs in emerging countries, and stringent regulations imposed by government and regulatory agencies to enhance the quality of pharmaceutical and biopharmaceutical products.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=42556211

Regional Growth Analysis:

North America is estimated to hold the largest share of the Track etched Membrane Market in 2018, followed by Europe and Asia Pacific. The large share of the North American market can be attributed to the increasing health and environmental concerns, increasing adoption of laboratory filtration equipment, and surge in the development of new biologics and growing pharmaceutical research.

Key Players:

Key players operating in the global Track etched Membrane are GE Healthcare (US), Danaher (US), Corning (US), Merck (Germany), it4ip (Belgium), Sterlitech (US), Oxyphen (Switzerland), Sarstedt (US), BRAND GMBH (Germany), Sartorius (Germany), SABEU (Germany), Zefon International (US), GVS (Italy), Thermo Fisher Scientific (US), Eaton (Ireland), Greiner Bio-One (Austria), MACHEREY-NAGEL (Germany), Avanti Lipids Polar (US), SKC (US), Advantec (Canada), Avestin (Canada), Scaffdex (Finland), and Graver Technologies (US).

GE Healthcare (US) provides an extensive portfolio of laboratory filtration products. The company’s Whatman 19mm Nuclepore Polycarbonate Hydrophilic Membranes combines high flow rates and chemical & thermal resistance with sharply defined pores, making them suitable for microscopy, cytology, parasitology, and certain air and oceanography analyses. The life sciences segment of the company continued to expand its business through product launches, organic investments, and acquisitions. The revenue of the life sciences division grew by 5% in 2017 as compared to 2016 and the bioprocess products division showed a growth of 9% in 2017.

collect
0
avatar
Research Net
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more